1 |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J]. CA Cancer J Clin, 2024, 74(3): 229-263.
|
2 |
安柯, 王延召, 王子龙, 等. 青年人群结直肠癌特点分析及中西方差异对比 [J/OL]. 中华临床医师杂志(电子版), 2021, 15(2): 139-143.
|
3 |
Landras A, Reger de Moura C, Jouenne F, et al. CD147 is a promising target of tumor progression and a prognostic biomarker [J]. Cancers (Basel), 2019, 11(11): 1803.
|
4 |
Dong S, Li S, Wang X, et al. CD147 mediates 5-fluorouracil resistance in colorectal cancer by reprogramming glycolipid metabolism [J]. Front Oncol, 2022, 12: 813852.
|
5 |
Nyalali AMK, Leonard AU, Xu Y, et al. CD147: an integral and potential molecule to abrogate hallmarks of cancer [J]. Front Oncol, 2023, 13: 1238051.
|
6 |
骆文雄. CD147、MMP-2及COTL-1在结直肠癌中的表达及临床意义的研究 [D]. 南华大学, 2019.
|
7 |
Li F, Wang J, Yan YQ, et al. CD147 promotes breast cancer migration and invasion by inducing epithelial-mesenchymal transition via the MAPK/ERK signaling pathway [J]. BMC Cancer, 2023, 23(1): 1214.
|
8 |
郑荣寿, 陈茹, 韩冰峰, 等. 2022年中国恶性肿瘤流行情况分析 [J]. 中华肿瘤杂志, 2024, 46(3): 221-231.
|
9 |
王露尧, 张鹭鹭. 中国结直肠癌发病和死亡情况及防控策略 [J]. 解放军医院管理杂志, 2021, 28(12): 1195-1197.
|
10 |
Frick C, Rumgay H, Vignat J, et al. Quantitative estimates of preventable and treatable deaths from 36 cancers worldwide: a population-based study [J]. Lancet Glob Health, 2023, 11(11): e1700-e1712.
|
11 |
Kanekura T. CD147/Basigin is involved in the development of malignant tumors and T-cell-mediated immunological disorders via regulation of glycolysis [J]. Int J Mol Sci, 2023, 24(24): 17344.
|
12 |
Zhang N, Liu Z, Lai X, et al. Silencing of CD147 inhibits cell proliferation, migration, invasion, lipid metabolism dysregulation and promotes apoptosis in lung adenocarcinoma via blocking the Rap1 signaling pathway [J]. Respir Res, 2023, 24(1): 253.
|
13 |
Knutti N, Huber O, Friedrich K. CD147 (EMMPRIN) controls malignant properties of breast cancer cells by interdependent signaling of Wnt and JAK/STAT pathways [J]. Mol Cell Biochem, 2019, 451(1-2): 197-209.
|
14 |
Reger de Moura C, Landras A, Khayati F, et al. CD147 promotes tumor lymphangiogenesis in melanoma via PROX-1 [J]. Cancers (Basel), 2021, 13(19): 4859.
|
15 |
Li X, Xu W. CD147-mediated reprogrammed glycolytic metabolism potentially induces immune escape in the tumor microenvironment (Review) [J]. Oncol Rep, 2019, 41(5): 2945-2956.
|
16 |
Guo YJ, Pan WW, Liu SB, et al. ERK/MAPK signalling pathway and tumorigenesis [J]. Exp Ther Med, 2020, 19(3): 1997-2007.
|
17 |
贾玲玲, 张文凯, 刘凯, 等. 参与调控细胞程序性死亡蛋白1及其配体1信号通路的研究进展 [J/OL].中华临床医师杂志(电子版), 2020, 14(2): 149-153.
|
18 |
Su C, Sun Q, Liu S, et al. Targeting p38γ to inhibit human colorectal cancer cell progression [J]. Biochem Biophys Res Commun, 2019, 517(1): 172-179.
|